Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the renewal of its multi ...

Using the 2 Stage Free Cash Flow to Equity, Clarivate fair value estimate is US$5.71. Clarivate's US$4.22 share price signals that it might be 26% undervalued. Our f ...

Clarivate Plc  (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, announced today that it has successfully completed an incremental upsize of its term loan B ...

MaxLinear, Inc. and Comtrend announced today the availability of ITU-T standards-based powerline data modules for EV Charging Stations (EVSE) backend communication, including data centers and smart ...

The proceeds of the new term loans were used to redeem $500 million aggregate principal amount of the outstanding 4.50% senior secured notes due 2026 originally issued on October 31, 2019. Following ...

It's in late-stage development for IgA nephropathy and focal segmental glomerulosclerosis (FSGS) with initial data suggesting ... It has been highlighted by Clarivate for its potential ability ...

F portfolio saw a modest increase in value. Check out the significant new stakes and major increases in the portfolio here.

Despite a recent data readout that disappointed investors and led to a steep decline in Novo Nordisk's share price, Clarivate is predicting G7 sales potential of $4.7 billion in obesity and $3.6 ...